Ha habido 50 transacciones internas recientes registradas para PTC Therapeutics, Inc. (PTCT), incluyendo 9 compras y 40 ventas. El total de compras internas fue valorado en $13.96M y el total de ventas internas en $6.06M.
Internos destacados con actividad reciente incluyen Golden Lee Scott, Almstead Neil Gregory, Chutter Jessica Caroline. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — PTCT
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-04-02 |
Golden Lee Scott |
EVP & Chief Medical Officer |
Venta Informativa |
829 |
$67.99 |
$56.36K |
79,115 |
| 2026-04-01 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
Venta Informativa |
80 |
$70.30 |
$5.62K |
60,137 |
| 2026-03-24 |
Chutter Jessica Caroline |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-03-24 |
Chutter Jessica Caroline |
Director |
Concesión de RSU |
2,896 |
$64.54 |
$186.91K |
2,896 |
| 2026-03-12 |
Klein Matthew B. |
Chief Executive Officer |
Venta Informativa |
2,662 |
$64.08 |
$170.58K |
396,920 |
| 2026-03-11 |
Klein Matthew B. |
Chief Executive Officer |
Concesión de RSU |
12,500 |
- |
- |
399,582 |
| 2026-03-10 |
Okey Stephanie |
Director |
Ejercicio de Opciones (Venta) |
14,000 |
$33.63 |
$470.82K |
- |
| 2026-03-05 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
Venta Informativa |
3,989 |
$63.38 |
$252.82K |
2,737 |
| 2026-03-05 |
Golden Lee Scott |
EVP & Chief Medical Officer |
Venta Informativa |
10,000 |
$63.38 |
$633.8K |
79,944 |
| 2026-03-05 |
Okey Stephanie |
Director |
Venta Informativa |
6,333 |
$63.38 |
$401.39K |
8,000 |
| 2026-02-19 |
Boulding Mark Elliott |
Exec. VP and CLO |
Venta Informativa |
590 |
$69.82 |
$41.19K |
105,212 |
| 2026-02-18 |
Boulding Mark Elliott |
Exec. VP and CLO |
Venta Informativa |
3,081 |
$69.36 |
$213.7K |
108,231 |
| 2026-02-18 |
Pauwels Eric |
Chief Business Officer |
Venta Informativa |
3,019 |
$69.36 |
$209.4K |
77,122 |
| 2026-02-18 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
Venta Informativa |
65 |
$69.36 |
$4.51K |
6,726 |
| 2026-02-18 |
Golden Lee Scott |
EVP & Chief Medical Officer |
Venta Informativa |
2,484 |
$69.36 |
$172.29K |
89,944 |
| 2026-02-18 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
Venta Informativa |
2,494 |
$69.36 |
$172.98K |
70,199 |
| 2026-02-18 |
Klein Matthew B. |
Chief Executive Officer |
Venta Informativa |
7,371 |
$69.36 |
$511.25K |
387,082 |
| 2026-02-18 |
Gravier Pierre |
Chief Financial Officer |
Venta Informativa |
2,992 |
$69.36 |
$207.53K |
87,318 |
| 2026-02-17 |
Boulding Mark Elliott |
Exec. VP and CLO |
Ejercicio de Opciones (Venta) |
2,813 |
$25.69 |
$72.27K |
22,501 |
| 2026-01-12 |
Pauwels Eric |
Chief Business Officer |
Venta Informativa |
1,024 |
$78.70 |
$80.59K |
80,141 |
| 2026-01-09 |
Pauwels Eric |
Chief Business Officer |
Venta Informativa |
1,722 |
$77.41 |
$133.3K |
81,165 |
| 2026-01-09 |
Boulding Mark Elliott |
Exec. VP and CLO |
Venta Informativa |
107 |
$79.52 |
$8.51K |
111,312 |
| 2026-01-08 |
Pauwels Eric |
Chief Business Officer |
Venta Informativa |
1,454 |
$76.45 |
$111.16K |
82,887 |
| 2026-01-08 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
Venta Informativa |
59 |
$76.45 |
$4.51K |
6,791 |
| 2026-01-08 |
Boulding Mark Elliott |
Exec. VP and CLO |
Venta Informativa |
1,286 |
$76.45 |
$98.31K |
113,626 |
| 2026-01-08 |
Golden Lee Scott |
EVP & Chief Medical Officer |
Venta Informativa |
866 |
$76.45 |
$66.21K |
92,428 |
| 2026-01-08 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
Venta Informativa |
1,034 |
$76.45 |
$79.05K |
72,693 |
| 2026-01-08 |
Klein Matthew B. |
Chief Executive Officer |
Venta Informativa |
2,514 |
$76.45 |
$192.2K |
394,453 |
| 2026-01-07 |
Pauwels Eric |
Chief Business Officer |
Venta Informativa |
1,352 |
$77.48 |
$104.75K |
87,489 |
| 2026-01-07 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
Venta Informativa |
52 |
$77.48 |
$4.03K |
6,850 |
| 2026-01-07 |
Boulding Mark Elliott |
Exec. VP and CLO |
Ejercicio de Opciones (Venta) |
751 |
$38.10 |
$28.61K |
- |
| 2026-01-07 |
Golden Lee Scott |
EVP & Chief Medical Officer |
Venta Informativa |
642 |
$77.48 |
$49.74K |
93,294 |
| 2026-01-07 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
Venta Informativa |
1,235 |
$77.45 |
$95.65K |
73,727 |
| 2026-01-07 |
Klein Matthew B. |
Chief Executive Officer |
Venta Informativa |
3,016 |
$77.48 |
$233.68K |
396,967 |
| 2026-01-06 |
Pauwels Eric |
Chief Business Officer |
Venta Informativa |
1,789 |
$76.95 |
$137.66K |
88,841 |
| 2026-01-06 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
Venta Informativa |
54 |
$76.95 |
$4.16K |
6,902 |
| 2026-01-06 |
Boulding Mark Elliott |
Exec. VP and CLO |
Venta Informativa |
1,739 |
$76.95 |
$133.82K |
119,162 |
| 2026-01-06 |
Golden Lee Scott |
EVP & Chief Medical Officer |
Venta Informativa |
1,340 |
$76.95 |
$103.11K |
93,936 |
| 2026-01-06 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
Venta Informativa |
1,381 |
$76.95 |
$106.27K |
74,962 |
| 2026-01-06 |
Klein Matthew B. |
Chief Executive Officer |
Venta Informativa |
5,149 |
$76.95 |
$396.22K |
399,983 |
| 2026-01-06 |
Gravier Pierre |
Chief Financial Officer |
Venta Informativa |
2,139 |
$76.95 |
$164.6K |
90,310 |
| 2026-01-05 |
Boulding Mark Elliott |
Exec. VP and CLO |
Ejercicio de Opciones (Venta) |
2,266 |
$39.42 |
$89.33K |
9,063 |
| 2026-01-05 |
Reeve Emma |
Director |
Ejercicio de Opciones (Venta) |
734 |
$46.54 |
$34.16K |
- |
| 2026-01-02 |
Pauwels Eric |
Chief Business Officer |
Concesión de RSU |
50,000 |
$76.74 |
$3.84M |
50,000 |
| 2026-01-02 |
Zeldis Jerome B |
Director |
Concesión de RSU |
3,475 |
$76.74 |
$266.67K |
3,475 |
| 2026-01-02 |
Almstead Neil Gregory |
Chief Technical Ops Officer |
Concesión de RSU |
520 |
- |
- |
6,956 |
| 2026-01-02 |
Boulding Mark Elliott |
Exec. VP and CLO |
Concesión de RSU |
42,500 |
$76.74 |
$3.26M |
42,500 |
| 2026-01-02 |
Reeve Emma |
Director |
Concesión de RSU |
3,475 |
$76.74 |
$266.67K |
3,475 |
| 2026-01-02 |
Golden Lee Scott |
EVP & Chief Medical Officer |
Concesión de RSU |
46,875 |
$76.74 |
$3.6M |
46,875 |
| 2026-01-02 |
Utter Christine Marie |
SVP, Chief Accounting Officer |
Concesión de RSU |
33,125 |
$76.74 |
$2.54M |
33,125 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
